Childhood Cancer

You are here

Acute Myelogenous Leukemia (AML)

Childhood acute myelogenous leukemia (AML) is a cancer of the myeloid cells that form white blood cells, red blood cells or platelets. AML is the second most common form of childhood leukemia. 

Latest Acute Myelogenous Leukemia (AML) grants

Zuzana Tothova, MD/PhD, Principal Investigator
Broad Institute
RUNX1 Early Career Investigator Grants, Awarded 2019
Todd Druley, MD/PhD, Principal Investigator
Washington University
Innovation Grants, Awarded 2018
Soheil Meshinchi, MD/PhD, Principal Investigator
Fred Hutchinson Cancer Research Center
Reach Grants, Awarded 2018

Latest Acute Myelogenous Leukemia (AML) blog posts

Every day, around the world, over 700 children are diagnosed with one of the hundreds of types of childhood cancer—the equivalent of an entire elementary school of children. 

And everyday, researchers, powered by Alex's Lemonade Stand... more
by Trish Adkins

For Eden, the trouble began when she was 10 years old. The trouble had a name: pain. It seemed normal at first—maybe a side effect from dancing or growing. But then it never went away and then, suddenly, Eden could not... more
Children with certain types of hard-to-treat childhood cancers just got another huge dose of hope. Last week, the U.S. Food and Drug Administration (FDA) granted accelerated approval to a drug called Vitrakvi (also known as larotrectinib... more